Ashish Nimgaonkar

Ashish Nimgaonkar

Company: Glyscend

Job title: Founder & Chief Executive Officer


Forging Success in Type 2 Diabetes: Treatment & Reversal of T2D & Interrogating Cross-Talk in Metabolic Syndrome 2:00 pm

Investigating cross talk in metabolic syndrome: from T2D to obesity to NASH Does T2D represent an attractive path to market? Understanding market access with opportunities and implications in NASH and obesity Pioneering a new generation of gut-targeted polymer therapies to achieve pharmacologic duodenal exclusion: targeting the root cause of metabolic syndrome, improving blood glucose, and…Read more

day: Day 2 Stream 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.